Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy

Name: Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitors and Radiotherapy
License: Public Domain

University of Erlangen-Nürnberg Medical School

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

nsclc renal-cell-carcinoma

hnscc, nsclc, esophageal cancer, urothelial carcinoma, renal cell carcinoma, squamous cell carcinoma of the skin

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 140999
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.